LAQUINTA KEE: Open Payments
NPI 1093324717 · SHELBY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 22 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $263 · 2025 $509
Food & beverage: $481Education: $27
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $150 |
| Janssen Pharmaceuticals, Inc | 2 | $116 |
| Collegium Pharmaceutical, Inc. | 5 | $80 |
| Supernus Pharmaceuticals, Inc. | 1 | $36 |
| Alkermes, Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: COBENFY, INVEGA SUSTENNA, Jornay PM, Qelbree, ARISTADA, INGREZZA, ABILIFY ASIMTUFII, FANAPT.
Industry payments across NC — which companies pay providers there.
